biomarkerstrategies.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | BioMarker Strategies |
| Description | BioMarker Strategies has developed the proprietary and recently patented SnapPath Cancer Diagnostics System for predictive tests to guide targeted drug de |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 209.17.116.8 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
biomarkerstrategies.com Valuation
|
US$2,053,575
Last updated: 2023-05-09 10:39:27
biomarkerstrategies.com has Semrush global rank of 5,154,088. biomarkerstrategies.com has an estimated worth of US$ 2,053,575, based on its estimated Ads revenue. biomarkerstrategies.com receives approximately 236,951 unique visitors each day. Its web server is located in United States, with IP address 209.17.116.8. According to SiteAdvisor, biomarkerstrategies.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,053,575 |
| Daily Ads Revenue | US$1,896 |
| Monthly Ads Revenue | US$56,869 |
| Yearly Ads Revenue | US$682,419 |
| Daily Unique Visitors | 15,797 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| biomarkerstrategies.com. 7199 | A | biomarkerstrategies.com. 7199 | IP: 209.17.116.8 |
| biomarkerstrategies.com. 7200 | NS | biomarkerstrategies.com. 7200 | NS Record: ns79.worldnic.com. |
| biomarkerstrategies.com. 7200 | NS | biomarkerstrategies.com. 7200 | NS Record: ns80.worldnic.com. |
| biomarkerstrategies.com. 7200 | MX | biomarkerstrategies.com. 7200 | MX Record: 10 biomarkerstrategies-com.mail.protection.outlook.com. |
| biomarkerstrategies.com. 7200 | TXT | biomarkerstrategies.com. 7200 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-09 10:39:27
| BioMarker Strategies has developed the proprietary and recently patented SnapPath Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. SnapPath ® is unique in automating and standardizing functional ex vivo profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. Our PathMAP ® Functional Signaling Profiles, created using the SnapPath ® system, represent a new class of biomarker tests that are highly predictive of individual response to targeted treatments for solid tumors, because they are based on information available only from live cells. Our business development efforts are directed toward entering into funded collaborations with companies developing targeted therapies for patients with solid tumors. The capabilities of SnapPath ® and the |
HTTP Headers
HTTP/1.1 200 OK Content-Length: 13109 Content-Type: text/html Last-Modified: Sat, 06 Jun 2020 13:05:12 GMT Accept-Ranges: bytes ETag: "dc545e1d33cd61:0" Server: Microsoft-IIS/10.0 X-Powered-By: ASP.NET X-Powered-By: ARR/3.0 Date: Sun, 31 Oct 2021 17:51:16 GMT |
biomarkerstrategies.com Whois Information
Domain Name: BIOMARKERSTRATEGIES.COM Registry Domain ID: 417109855_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-02-17T08:28:34Z Creation Date: 2006-04-18T23:59:29Z Registry Expiry Date: 2026-04-18T23:59:29Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS79.WORLDNIC.COM Name Server: NS80.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T03:33:47Z <<< |